Multiple Myeloma

Anitha Thomas, Shyam M. Garg, Rebecca A. G. De Souza, Eric Ouellet, Grace Tharmarajah, Dave Reichert, Mina Ordobadi, Shell Ip, Euan C. Ramsay, Thomas, Anitha, Garg, Shyam M., Souza, Rebecca A. G. De, Ouellet, Eric, Tharmarajah, Grace, Reichert, Dave, Ordobadi, Mina, Ip, Shell, Ramsay, Euan C.

Lipid nanoparticles (LNPs) are established in the biopharmaceutical industry for efficient encapsulation and cytosolic delivery of nucleic acids for potential therapeutics, with several formulations in clinical trials. The advantages of LNPs can also be applied in basic research and discovery with a microfluidic method of preparation now commercially available that allows preparations to be scaled down to quantities appropriate for cell culture. These preparations conserve expensive nucleic acids while maintaining the particle characteristics that have made LNPs successful in later stages of genetic medicine development. Additionally, this method and the resulting LNPs are seamlessly scalable to quantities appropriate for in vivo models and development of nucleic acid therapeutics.The present work describes the methodology for preparing LNPs loaded with siRNA, mRNA or plasmids using a commercially available microfluidic instrument and an accompanying transfection kit. Guidelines for application to cultured cells in a well-plate format are also provided.